- Home
- SBFM vs BBLG Comparison
SBFM vs BBLG Comparison
Compare SBFM & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- BBLG
- Stock Information
- Founded
- SBFM 2006
- BBLG 2004
- Country
- SBFM United States
- BBLG United States
- Employees
- SBFM N/A
- BBLG N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- BBLG Industrial Specialties
- Sector
- SBFM Health Care
- BBLG Health Care
- Exchange
- SBFM Nasdaq
- BBLG Nasdaq
- Market Cap
- SBFM 3.7M
- BBLG 3.3M
- IPO Year
- SBFM N/A
- BBLG N/A
- Fundamental
- Price
- SBFM $3.00
- BBLG $1.81
- Analyst Decision
- SBFM
- BBLG
- Analyst Count
- SBFM 0
- BBLG 0
- Target Price
- SBFM N/A
- BBLG N/A
- AVG Volume (30 Days)
- SBFM 153.8K
- BBLG 622.1K
- Earning Date
- SBFM 11-11-2024
- BBLG 11-12-2024
- Dividend Yield
- SBFM N/A
- BBLG N/A
- EPS Growth
- SBFM N/A
- BBLG N/A
- EPS
- SBFM N/A
- BBLG N/A
- Revenue
- SBFM $30,481,982.00
- BBLG N/A
- Revenue This Year
- SBFM $86.70
- BBLG N/A
- Revenue Next Year
- SBFM $126.76
- BBLG N/A
- P/E Ratio
- SBFM N/A
- BBLG N/A
- Revenue Growth
- SBFM 109.82
- BBLG N/A
- 52 Week Low
- SBFM $2.42
- BBLG $0.80
- 52 Week High
- SBFM $660.00
- BBLG $10.56
- Technical
- Relative Strength Index (RSI)
- SBFM 46.45
- BBLG 51.38
- Support Level
- SBFM $2.85
- BBLG $1.45
- Resistance Level
- SBFM $3.05
- BBLG $2.04
- Average True Range (ATR)
- SBFM 0.15
- BBLG 0.26
- MACD
- SBFM 0.02
- BBLG -0.03
- Stochastic Oscillator
- SBFM 43.59
- BBLG 36.00
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.